Calumet, Inc. $CLMT Shares Bought by Citigroup Inc.

Citigroup Inc. raised its position in Calumet, Inc. (NASDAQ:CLMT) by 111.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 180,779 shares of the oil and gas company’s stock after purchasing an additional 95,383 shares during the period. Citigroup Inc.’s holdings in Calumet were worth $3,299,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Great Lakes Advisors LLC acquired a new stake in Calumet during the 3rd quarter worth $3,088,000. Two Seas Capital LP raised its holdings in shares of Calumet by 56.9% in the second quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock valued at $70,860,000 after buying an additional 1,631,098 shares during the last quarter. Intech Investment Management LLC acquired a new stake in shares of Calumet during the second quarter worth about $518,000. SP Asset Management LLC purchased a new position in shares of Calumet during the second quarter worth about $205,000. Finally, AYAL Capital Advisors Ltd acquired a new position in Calumet in the 2nd quarter valued at about $5,278,000. 34.41% of the stock is currently owned by hedge funds and other institutional investors.

Calumet Stock Up 3.3%

NASDAQ:CLMT opened at $30.29 on Friday. Calumet, Inc. has a 52-week low of $7.68 and a 52-week high of $30.52. The stock has a fifty day simple moving average of $23.77 and a 200-day simple moving average of $20.32. The company has a market capitalization of $2.63 billion, a PE ratio of -77.66 and a beta of 1.18.

Calumet (NASDAQ:CLMT) last issued its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, beating analysts’ consensus estimates of ($0.67) by $0.24. The business had revenue of ($3,098.50) million during the quarter, compared to analyst estimates of $1.04 billion. Calumet’s revenue was up 9.4% on a year-over-year basis. During the same period in the previous year, the company posted ($0.47) earnings per share. As a group, equities analysts anticipate that Calumet, Inc. will post -3.02 earnings per share for the current year.

Key Calumet News

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright keeps a “Buy” rating and a $33 price target on CLMT, a level above the current price that supports upside expectations for investors. The firm continues to publish multi-year recovery forecasts despite near-term losses. HC Wainwright Research Coverage
• Neutral Sentiment: Reported short-interest data shows 0 shares short and a 0.0 days-to-cover metric — likely a reporting anomaly. If accurate, negligible short interest removes a potential downside pressure, but the entry appears unreliable and should be viewed cautiously.
• Neutral Sentiment: A FY2029 earnings forecast was published by HC Wainwright (reported on AmericanBankingNews), but the item provides a forward-looking projection without new operational details; useful for modeling but not an immediate catalyst. FY2029 Forecast
• Neutral Sentiment: A PR Newswire release highlights record sales for TRUFUEL®. If TRUFUEL is part of Calumet’s branded products mix, rising consumer/retail sales support longer-term revenue diversification; however, the release is a general industry/brand sales item rather than direct corporate financial guidance. TRUFUEL Record Sales
• Negative Sentiment: TD Cowen raised its price target from $19 to $25 but maintained a “Hold” rating — their $25 target implies downside relative to the current trade level, signaling limited near-term upside from this shop and offering a mixed signal despite the higher target. TD Cowen Target Update
• Negative Sentiment: HC Wainwright materially lowered near- and medium-term EPS forecasts (FY2026, FY2027 and FY2028 revisions downward), trimming FY2026 to a larger loss and reducing FY2028 upside. Those cuts are a direct negative to valuation and short-term expectations despite the maintained Buy rating and $33 target. HC Wainwright EPS Revisions

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CLMT shares. The Goldman Sachs Group increased their price objective on Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. HC Wainwright reaffirmed a “buy” rating and set a $33.00 price target on shares of Calumet in a report on Monday, November 10th. Wall Street Zen cut shares of Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. UBS Group restated a “neutral” rating and issued a $26.00 target price on shares of Calumet in a research note on Friday, February 13th. Finally, TD Cowen lifted their target price on shares of Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a report on Thursday. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $24.00.

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.